NO792633L - Fremgangsmaate og sammensetning for noeytralisering eller oedeleggelse av virus - Google Patents

Fremgangsmaate og sammensetning for noeytralisering eller oedeleggelse av virus

Info

Publication number: NO792633L
Authority: NO; Norway
Prior art keywords: virus; glutaric acid; virucidal; viruses; living
Prior art date: 1978-08-14

Application number

NO792633A

Other languages

English (en)

Norwegian (no)

Inventor

Guy Dominic Diana

Original Assignee

Sterling Drug Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1978-08-14

Filing date

1979-08-13

Publication date

1980-02-15

1979-08-13 Application filed by Sterling Drug Inc filed Critical Sterling Drug Inc

1980-02-15 Publication of NO792633L publication Critical patent/NO792633L/no

Links

241000700605 Viruses Species 0.000 title claims description 50
239000000203 mixture Substances 0.000 title claims description 22
238000000034 method Methods 0.000 title description 3
230000006378 damage Effects 0.000 title 1
238000006386 neutralization reaction Methods 0.000 title 1
RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 claims description 42
JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 claims description 42
230000003253 viricidal effect Effects 0.000 claims description 22
241000709661 Enterovirus Species 0.000 claims description 12
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
239000000645 desinfectant Substances 0.000 claims description 7
241000712461 unidentified influenza virus Species 0.000 claims description 4
241000725643 Respiratory syncytial virus Species 0.000 claims description 3
239000004094 surface-active agent Substances 0.000 claims description 3
229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 2
208000002606 Paramyxoviridae Infections Diseases 0.000 claims description 2
241000700584 Simplexvirus Species 0.000 claims description 2
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 2
239000001768 carboxy methyl cellulose Substances 0.000 claims description 2
235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 2
239000008112 carboxymethyl-cellulose Substances 0.000 claims description 2
238000009472 formulation Methods 0.000 claims description 2
239000011780 sodium chloride Substances 0.000 claims description 2
239000002904 solvent Substances 0.000 claims description 2
239000004902 Softening Agent Substances 0.000 claims 1
238000012360 testing method Methods 0.000 description 16
239000000243 solution Substances 0.000 description 11
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
239000012530 fluid Substances 0.000 description 9
POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 8
235000013601 eggs Nutrition 0.000 description 8
239000000523 sample Substances 0.000 description 7
238000005406 washing Methods 0.000 description 7
230000003013 cytotoxicity Effects 0.000 description 6
231100000135 cytotoxicity Toxicity 0.000 description 6
239000011521 glass Substances 0.000 description 6
241000283973 Oryctolagus cuniculus Species 0.000 description 5
244000100945 Piper peltatum Species 0.000 description 5
210000004027 cell Anatomy 0.000 description 5
235000019441 ethanol Nutrition 0.000 description 5
POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 4
229960000458 allantoin Drugs 0.000 description 4
238000010790 dilution Methods 0.000 description 4
239000012895 dilution Substances 0.000 description 4
210000001519 tissue Anatomy 0.000 description 4
241001251094 Formica Species 0.000 description 3
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
230000001476 alcoholic effect Effects 0.000 description 3
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 3
239000012153 distilled water Substances 0.000 description 3
230000000694 effects Effects 0.000 description 3
239000006260 foam Substances 0.000 description 3
239000002953 phosphate buffered saline Substances 0.000 description 3
238000002360 preparation method Methods 0.000 description 3
238000004448 titration Methods 0.000 description 3
241000991587 Enterovirus C Species 0.000 description 2
241000287828 Gallus gallus Species 0.000 description 2
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
230000005540 biological transmission Effects 0.000 description 2
239000003795 chemical substances by application Substances 0.000 description 2
150000001875 compounds Chemical class 0.000 description 2
239000003814 drug Substances 0.000 description 2
229940079593 drug Drugs 0.000 description 2
238000001035 drying Methods 0.000 description 2
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
230000000855 fungicidal effect Effects 0.000 description 2
239000007788 liquid Substances 0.000 description 2
238000002941 microtiter virus yield reduction assay Methods 0.000 description 2
230000000644 propagated effect Effects 0.000 description 2
239000000344 soap Substances 0.000 description 2
239000000126 substance Substances 0.000 description 2
230000000699 topical effect Effects 0.000 description 2
BUAJNGPDPGKBGV-UHFFFAOYSA-N 1-(1-phenylcyclohexyl)piperidin-1-ium;chloride Chemical compound [Cl-].C1CCCC[NH+]1C1(C=2C=CC=CC=2)CCCCC1 BUAJNGPDPGKBGV-UHFFFAOYSA-N 0.000 description 1
241001103808 Albifimbria verrucaria Species 0.000 description 1
241000228245 Aspergillus niger Species 0.000 description 1
108091003079 Bovine Serum Albumin Proteins 0.000 description 1
241000222122 Candida albicans Species 0.000 description 1
241000282693 Cercopithecidae Species 0.000 description 1
208000035473 Communicable disease Diseases 0.000 description 1
241001466953 Echovirus Species 0.000 description 1
241000709714 Echovirus E11 Species 0.000 description 1
241000709643 Echovirus E9 Species 0.000 description 1
241000712003 Human respirovirus 3 Species 0.000 description 1
XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
241000282560 Macaca mulatta Species 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
241001149951 Mucor mucedo Species 0.000 description 1
229910019142 PO4 Inorganic materials 0.000 description 1
235000014676 Phragmites communis Nutrition 0.000 description 1
239000004698 Polyethylene Substances 0.000 description 1
241001045770 Trichophyton mentagrophytes Species 0.000 description 1
208000036142 Viral infection Diseases 0.000 description 1
239000002253 acid Substances 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
230000004913 activation Effects 0.000 description 1
239000000443 aerosol Substances 0.000 description 1
230000007815 allergy Effects 0.000 description 1
229940095731 candida albicans Drugs 0.000 description 1
125000004432 carbon atom Chemical group C* 0.000 description 1
239000000969 carrier Substances 0.000 description 1
210000003837 chick embryo Anatomy 0.000 description 1
210000000795 conjunctiva Anatomy 0.000 description 1
230000000120 cytopathologic effect Effects 0.000 description 1
231100000433 cytotoxic Toxicity 0.000 description 1
230000001472 cytotoxic effect Effects 0.000 description 1
150000001991 dicarboxylic acids Chemical class 0.000 description 1
239000003085 diluting agent Substances 0.000 description 1
125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
239000000975 dye Substances 0.000 description 1
239000003974 emollient agent Substances 0.000 description 1
210000003743 erythrocyte Anatomy 0.000 description 1
239000012894 fetal calf serum Substances 0.000 description 1
230000002538 fungal effect Effects 0.000 description 1
230000035931 haemagglutination Effects 0.000 description 1
210000004209 hair Anatomy 0.000 description 1
230000003699 hair surface Effects 0.000 description 1
208000015181 infectious disease Diseases 0.000 description 1
230000001524 infective effect Effects 0.000 description 1
238000011835 investigation Methods 0.000 description 1
210000003734 kidney Anatomy 0.000 description 1
239000000314 lubricant Substances 0.000 description 1
230000003641 microbiacidal effect Effects 0.000 description 1
210000004400 mucous membrane Anatomy 0.000 description 1
230000003472 neutralizing effect Effects 0.000 description 1
235000015097 nutrients Nutrition 0.000 description 1
239000002674 ointment Substances 0.000 description 1
150000002894 organic compounds Chemical class 0.000 description 1
239000002304 perfume Substances 0.000 description 1
230000002085 persistent effect Effects 0.000 description 1
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
239000010452 phosphate Substances 0.000 description 1
-1 polyethylene Polymers 0.000 description 1
229920000573 polyethylene Polymers 0.000 description 1
239000003755 preservative agent Substances 0.000 description 1
230000000069 prophylactic effect Effects 0.000 description 1
238000011084 recovery Methods 0.000 description 1
241000894007 species Species 0.000 description 1
238000005507 spraying Methods 0.000 description 1
239000003381 stabilizer Substances 0.000 description 1
239000000725 suspension Substances 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
238000000954 titration curve Methods 0.000 description 1
239000003860 topical agent Substances 0.000 description 1
230000035899 viability Effects 0.000 description 1
230000009385 viral infection Effects 0.000 description 1
230000003612 virological effect Effects 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
- A01N37/02—Saturated carboxylic acids or thio analogues thereof; Derivatives thereof
- A01N37/04—Saturated carboxylic acids or thio analogues thereof; Derivatives thereof polybasic
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32061—Methods of inactivation or attenuation
- C12N2770/32063—Methods of inactivation or attenuation by chemical treatment

Landscapes

Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Virology (AREA)
Genetics & Genomics (AREA)
Veterinary Medicine (AREA)
Communicable Diseases (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Immunology (AREA)
Oncology (AREA)
Animal Behavior & Ethology (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
Pharmacology & Pharmacy (AREA)
Microbiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
Agronomy & Crop Science (AREA)
Pest Control & Pesticides (AREA)
Plant Pathology (AREA)
Dentistry (AREA)
Environmental Sciences (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

NO792633A 1978-08-14 1979-08-13 Fremgangsmaate og sammensetning for noeytralisering eller oedeleggelse av virus NO792633L (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US93360278A	1978-08-14	1978-08-14

Publications (1)

Publication Number	Publication Date
NO792633L true NO792633L (no)	1980-02-15

Family

ID=25464222

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO792633A NO792633L (no)	1978-08-14	1979-08-13	Fremgangsmaate og sammensetning for noeytralisering eller oedeleggelse av virus

Country Status (16)

Country	Link
EP (1)	EP0008121B1 (de)
JP (1)	JPS5531078A (de)
AR (1)	AR220769A1 (de)
AT (1)	AT368356B (de)
AU (1)	AU526595B2 (de)
CA (1)	CA1138335A (de)
DE (1)	DE2964902D1 (de)
DK (1)	DK338879A (de)
ES (1)	ES483358A1 (de)
FI (1)	FI792495A7 (de)
IE (1)	IE48397B1 (de)
IL (1)	IL58009A (de)
NO (1)	NO792633L (de)
NZ (1)	NZ191277A (de)
PT (1)	PT70063A (de)
ZA (1)	ZA794204B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0049354A3 (de) *	1980-09-08	1983-02-23	Sterling Drug Inc.	Mischung zur therapeutischen, antiviralen Verwendung sowie Artikel und Packungen, die diese Mischung enthalten
DK315482A (da) *	1981-07-20	1983-01-21	Kimberly Clark Co	Fremgangsmaade til hindring af spredning af aandedraetsvira og middel til anvendelse ved fremgangsmaaden
US4828912A (en) *	1981-07-20	1989-05-09	Kimberly-Clark Corporation	Virucidal product having virucidal and/or germicidal properties
US4738847A (en) *	1985-01-14	1988-04-19	Kimberly-Clark Corporation	Multi-ply virucidal product
AT382310B (de) *	1985-09-30	1987-02-10	Horst Felsch	Verfahren zur entkalkung, desinfektion und reinigung von mundduschen usw.
US6238682B1 (en)	1993-12-13	2001-05-29	The Procter & Gamble Company	Anhydrous skin lotions having antimicrobial components for application to tissue paper products which mitigate the potential for skin irritation
AU1096101A (en) *	1999-10-19	2001-04-30	Procter & Gamble Company, The	Antimicrobial compositions comprising a dicarboxylic acid and a metal salt
US20050232868A1 (en) *	1999-10-19	2005-10-20	The Procter & Gamble Company	Methods of entrapping, inactivating, and removing viral infections by the administration of respiratory tract compositions
AU1095801A (en) *	1999-10-19	2001-04-30	Procter & Gamble Company, The	Antimicrobial compositions comprising a biologically active organic acid
BRPI0414543A (pt) *	2003-09-19	2006-11-07	Otsuka Pharma Co Ltd	promotor de secreção de beta-defensina humana
US8741954B2 (en)	2007-02-21	2014-06-03	Viratox, L.L.C.	Synergistic enhancement of calcium propionate

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2227861B1 (de) *	1973-05-04	1976-07-02	Anvar

1979
- 1979-08-08 IL IL58009A patent/IL58009A/xx unknown
- 1979-08-09 EP EP79102884A patent/EP0008121B1/de not_active Expired
- 1979-08-09 DE DE7979102884T patent/DE2964902D1/de not_active Expired
- 1979-08-10 NZ NZ191277A patent/NZ191277A/en unknown
- 1979-08-10 AU AU49798/79A patent/AU526595B2/en not_active Ceased
- 1979-08-10 FI FI792495A patent/FI792495A7/fi not_active Application Discontinuation
- 1979-08-13 DK DK338879A patent/DK338879A/da not_active Application Discontinuation
- 1979-08-13 IE IE1554/79A patent/IE48397B1/en unknown
- 1979-08-13 ES ES483358A patent/ES483358A1/es not_active Expired
- 1979-08-13 ZA ZA00794204A patent/ZA794204B/xx unknown
- 1979-08-13 NO NO792633A patent/NO792633L/no unknown
- 1979-08-14 AR AR277714A patent/AR220769A1/es active
- 1979-08-14 CA CA000333730A patent/CA1138335A/en not_active Expired
- 1979-08-14 JP JP10348479A patent/JPS5531078A/ja active Pending
- 1979-08-14 PT PT70063A patent/PT70063A/pt unknown
- 1979-08-14 AT AT0553279A patent/AT368356B/de not_active IP Right Cessation

Also Published As

Publication number	Publication date
AU526595B2 (en)	1983-01-20
FI792495A7 (fi)	1981-01-01
ZA794204B (en)	1980-08-27
NZ191277A (en)	1984-07-06
AR220769A1 (es)	1980-11-28
IL58009A0 (en)	1979-12-30
IL58009A (en)	1982-11-30
IE791554L (en)	1980-02-14
DK338879A (da)	1980-02-15
JPS5531078A (en)	1980-03-05
PT70063A (en)	1979-09-01
AT368356B (de)	1982-10-11
IE48397B1 (en)	1985-01-09
EP0008121B1 (de)	1983-02-23
DE2964902D1 (en)	1983-03-31
CA1138335A (en)	1982-12-28
EP0008121A1 (de)	1980-02-20
ES483358A1 (es)	1980-04-16
ATA553279A (de)	1982-02-15
AU4979879A (en)	1980-02-21

Publication	Publication Date	Title
KR870002047B1 (ko)	1987-12-03	비루스 박멸용 조성물 및 제품
US4828912A (en)	1989-05-09	Virucidal product having virucidal and/or germicidal properties
US4897304A (en)	1990-01-30	Virucidal composition, the method of use and the product therefor
De Benedictis et al.	2007	Inactivation of avian influenza viruses by chemical agents and physical conditions: a review
US4767788A (en)	1988-08-30	Glutaric acid virucidal processes and compositions
US7902258B2 (en)	2011-03-08	Methods for preventing lesions caused by viruses of the Herpesviridae or Poxviridae family
NO792633L (no)	1980-02-15	Fremgangsmaate og sammensetning for noeytralisering eller oedeleggelse av virus
US6458346B1 (en)	2002-10-01	Broad spectrum microbicidal and spermicidal compositions, devices, and methods
Tyler et al.	1987	A surface test for virucidal activity of disinfectants: preliminary study with herpes virus
CN111388391A (zh)	2020-07-10	一种茶树精油与乙醇双消杀免洗洗手液及制备方法
CA2439413C (en)	2017-01-03	Virucidal compositions
EP0190797A2 (de)	1986-08-13	Verfahren zur Vernichtung von Viren und Zusammensetzung dafür
US4200655A (en)	1980-04-29	Benzyl alcohol virucidal process
CA2114470A1 (en)	1994-07-30	Glutaraldehyde composition
Eggers	1990	Experiments on antiviral activity of hand disinfectants. Some theoretical and practical considerations
JP2567401B2 (ja)	1996-12-25	殺ウイルス用シート
CN114377104A (zh)	2022-04-22	一种精油组合物、制备方法及应用
CN113855782B (zh)	2022-05-20	天麻多肽在制备抗新冠病毒的外用防护产品中的用途
US5674829A (en)	1997-10-07	Stable aqueous glutaraldehyde solutions containing sodium acetate and a nonionic detergent
Mihai et al.	2011	Survival of H5N1 influenza virus in water and its inactivation by chemical methods
JPS58135802A (ja)	1983-08-12	殺ウイルス法、殺ウイルス組成物およびウイルス製品
Ansari et al.	2002	The need and methods for assessing the activity of topical agents against viruses
CN118678951A (zh)	2024-09-20	施加组合物来防止病毒传播
Cooke et al.	1965	AN ANTIVIRAL SUBSTANCE FROM PENICILLIUM CYANEO-FULVUM BIOURGE: II. BIOLOGICAL ACTIVITIES AGAINST RNA-CONTAINING VIRUSES
Taleat et al.	2020	Covid-19 and the Virucidal Efficacy of Sanitizing Agents: A Review